Latest News

Rising employer premiums averaging 9.5% erode wages, forcing workers to delay care.

FY2026 preserves HIV funding but level funding can't support long-acting therapeutics or growing needs.

FTC complaint against major PBMs for anticompetitive rebating and insulin pricing.

Q3 2024 Watch monitoring HCV treatment access across ADAPs, Medicaid, Veterans programs, and assistance initiatives.

How payor cost-containment strategies drive health disparities and limit care access.

PBM practices and supply chain vulnerabilities enable counterfeit drug distribution.

2024 federal healthcare policy priorities: 340B reform, PBM oversight, and telehealth.

Preview of 2023 federal regulatory priorities: Section 1557, IRA implementation, and prior authorization reform.

AMA survey: 93% of providers say prior authorizations delay care with 91% reporting negative clinical impact.

Biden's SOTU addresses harm reduction, endorses MAT Act; limited HIV-specific programming focus.

Copay accumulator programs block patient assistance from counting toward deductibles; HELP Copays Act needed.

Examines CMS's rebate rule on copay accumulator programs that block patient assistance from counting toward deductibles.